All patients were evaluated for tumour and node response using response evaluation criteria in solid tumour (RECIST) criteri, acute and late toxicities according to CTCAE version 3.0 (common terminology criteria for adverse events), RTOG / EORTC (Toxicity criteria of the Radiation Therapy Oncology Group / the European Organization for Research and Treatment of Cancer).